Literature DB >> 30047193

HOTAIR, a long noncoding RNA, is a marker of abnormal cell cycle regulation in lung cancer.

Minghui Liu1, Hongyi Zhang1, Ying Li2, Rui Wang3, Yongwen Li2, Hongbing Zhang1, Dian Ren1, Hongyu Liu2, Chunsheng Kang4, Jun Chen1,2.   

Abstract

Dysregulation of the cell cycle is a key indicator of tumors, including lung cancer. Recently, the study of cell cycle inhibitors has made great progress in relation to lung cancer. However, the question of what kinds of patients can use cell cycle inhibitors has plagued us. Therefore, seeking an accurate and convenient marker for the abnormal cell cycle in lung cancer is very important. In the present research, we showed that lncRNA HOTAIR is an optimal indicator of cell cycle dysregulation in lung cancer. In the present study, we investigated HOTAIR-specific expression in lung primary tumor samples by analyzing the TCGA public database and 67 pairs of patients' tissues collected from our department. Through the TCGA public database KEGG analysis, HOTAIR correlates with the cell cycle pathway. We identified that HOTAIR and its 2 segments, HOTAIR3' and HOTAIR5', promote the cell cycle passing through the restriction point during G1-S phase by regulating the Rb-E2F pathway and influence non-small-cell lung cancer cell proliferation, migration and invasion through epithelial-mesenchymal transition (EMT) and the β-catenin pathway in vitro and vivo. Finally, we showed that the high expression of HOTAIR was associated with resistance to gefitinib through the dysregulated cell cycle. In conclusion, HOTAIR could be an ideal indicator of cell cycle dysregulation and guide the use of cell cycle inhibitors.
© 2018 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.

Entities:  

Keywords:  EMT; HOTAIR; cell cycle; lung cancer; β-catenin

Mesh:

Substances:

Year:  2018        PMID: 30047193      PMCID: PMC6125477          DOI: 10.1111/cas.13745

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  50 in total

Review 1.  The emerging role of lncRNAs in cancer.

Authors:  Maite Huarte
Journal:  Nat Med       Date:  2015-11       Impact factor: 53.440

Review 2.  Current Challenges in Cancer Treatment.

Authors:  Jon Zugazagoitia; Cristiano Guedes; Santiago Ponce; Irene Ferrer; Sonia Molina-Pinelo; Luis Paz-Ares
Journal:  Clin Ther       Date:  2016-05-02       Impact factor: 3.393

3.  Long noncoding RNA as modular scaffold of histone modification complexes.

Authors:  Miao-Chih Tsai; Ohad Manor; Yue Wan; Nima Mosammaparast; Jordon K Wang; Fei Lan; Yang Shi; Eran Segal; Howard Y Chang
Journal:  Science       Date:  2010-07-08       Impact factor: 47.728

Review 4.  Senescence in Health and Disease.

Authors:  Shenghui He; Norman E Sharpless
Journal:  Cell       Date:  2017-06-01       Impact factor: 41.582

5.  PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro.

Authors:  Richard S Finn; Judy Dering; Dylan Conklin; Ondrej Kalous; David J Cohen; Amrita J Desai; Charles Ginther; Mohammad Atefi; Isan Chen; Camilla Fowst; Gerret Los; Dennis J Slamon
Journal:  Breast Cancer Res       Date:  2009       Impact factor: 6.466

6.  EGFR-tyrosine kinase inhibitor treatment in a patient with advanced non-small cell lung cancer and concurrent exon 19 and 21 EGFR mutations: A case report and review of the literature.

Authors:  Yang Yang; Biao Zhang; Rutian Li; Baorui Liu; Lifeng Wang
Journal:  Oncol Lett       Date:  2016-04-05       Impact factor: 2.967

Review 7.  CDK4/6 blockade in breast cancer: current experience and future perspectives.

Authors:  Dimitrios Zardavas; Noam Pondé; Konstantinos Tryfonidis
Journal:  Expert Opin Investig Drugs       Date:  2017-10-23       Impact factor: 6.206

Review 8.  K-Ras Mutations in Non-Small-Cell Lung Cancer: Prognostic and Predictive Value.

Authors:  Manolo D'Arcangelo; Federico Cappuzzo
Journal:  ISRN Mol Biol       Date:  2012-05-14

Review 9.  A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives.

Authors:  Alessandro Russo; Tindara Franchina; Giuseppina Rosaria Rita Ricciardi; Antonio Picone; Giuseppa Ferraro; Mariangela Zanghì; Giuseppe Toscano; Antonio Giordano; Vincenzo Adamo
Journal:  Oncotarget       Date:  2015-09-29

10.  Long noncoding RNA HOTAIR is relevant to cellular proliferation, invasiveness, and clinical relapse in small-cell lung cancer.

Authors:  Hiroshi Ono; Noriko Motoi; Hiroko Nagano; Eisaku Miyauchi; Masaru Ushijima; Masaaki Matsuura; Sakae Okumura; Makoto Nishio; Tetsuro Hirose; Naohiko Inase; Yuichi Ishikawa
Journal:  Cancer Med       Date:  2014-03-03       Impact factor: 4.452

View more
  30 in total

Review 1.  Analytical ultracentrifuge: an ideal tool for characterization of non-coding RNAs.

Authors:  Maulik D Badmalia; M Quadir Siddiqui; Tyler Mrozowich; Darren L Gemmill; Trushar R Patel
Journal:  Eur Biophys J       Date:  2020-10-16       Impact factor: 1.733

2.  HOTAIR, a long noncoding RNA, is a marker of abnormal cell cycle regulation in lung cancer.

Authors:  Minghui Liu; Hongyi Zhang; Ying Li; Rui Wang; Yongwen Li; Hongbing Zhang; Dian Ren; Hongyu Liu; Chunsheng Kang; Jun Chen
Journal:  Cancer Sci       Date:  2018-09       Impact factor: 6.716

3.  Long noncoding RNA KCNQ1 opposite strand/antisense transcript 1 promotes osteosarcoma progression through miR-154-3p/KLF12.

Authors:  Qibo Zhang; Huachang Jiang; Youming Jin; Ning Zhang; Zhihua Mu; Yan Guo; Haitao Li
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

4.  A comprehensive evaluation of differentially expressed mRNAs and lncRNAs in cystitis glandularis with gene ontology, KEGG pathway, and ceRNA network analysis.

Authors:  Chao Li; Jiao Hu; Peihua Liu; Qiaqia Li; Jinbo Chen; Yu Cui; Xu Zhou; Bichen Xue; Xin Zhang; Xin Gao; Xiongbing Zu
Journal:  Transl Androl Urol       Date:  2020-04

Review 5.  Long non-coding RNAs in hematological malignancies: translating basic techniques into diagnostic and therapeutic strategies.

Authors:  Nonthaphat Kent Wong; Chien-Ling Huang; Rashidul Islam; Shea Ping Yip
Journal:  J Hematol Oncol       Date:  2018-11-22       Impact factor: 17.388

6.  Long non-coding RNA SNAI3-AS1 promotes the proliferation and metastasis of hepatocellular carcinoma by regulating the UPF1/Smad7 signalling pathway.

Authors:  Yarui Li; Dan Guo; Mudan Ren; Yan Zhao; Xin Wang; Yifei Chen; Yaping Liu; Guifang Lu; Shuixiang He
Journal:  J Cell Mol Med       Date:  2019-07-02       Impact factor: 5.310

Review 7.  Long Non-Coding RNA in the Pathogenesis of Cancers.

Authors:  Yujing Chi; Di Wang; Junpei Wang; Weidong Yu; Jichun Yang
Journal:  Cells       Date:  2019-09-01       Impact factor: 6.600

8.  A methylation-based nomogram for predicting survival in patients with lung adenocarcinoma.

Authors:  Xuelong Wang; Bin Zhou; Yuxin Xia; Jianxin Zuo; Yanchao Liu; Xin Bi; Xiong Luo; Chengwei Zhang
Journal:  BMC Cancer       Date:  2021-07-12       Impact factor: 4.430

Review 9.  Probing lncRNA-Protein Interactions: Data Repositories, Models, and Algorithms.

Authors:  Lihong Peng; Fuxing Liu; Jialiang Yang; Xiaojun Liu; Yajie Meng; Xiaojun Deng; Cheng Peng; Geng Tian; Liqian Zhou
Journal:  Front Genet       Date:  2020-01-31       Impact factor: 4.599

10.  Long Non-coding RNA FIRRE Acts as a miR-520a-3p Sponge to Promote Gallbladder Cancer Progression via Mediating YOD1 Expression.

Authors:  Shuqing Wang; Yang Wang; Shouhua Wang; Huanjun Tong; Zhaohui Tang; Jiandong Wang; Yongjie Zhang; Jingmin Ou; Zhiwei Quan
Journal:  Front Genet       Date:  2021-06-08       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.